2024년 골유착 임플란트 세계 시장 규모는 71억 1,418만 달러로 평가되었습니다. 향후 IMARC Group은 이 시장이 2033년까지 113억 4,232만 달러에 달하고, 2025-2033년 5.05%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측했습니다. 현재 북미가 시장을 독점하고 있으며, 2024년 시장 점유율은 55.8%를 초과했습니다. 이 시장의 주요 원동력은 고령화 인구 증가, 치과 및 정형외과 시술에 대한 수요 증가, 임플란트 기술 발전, 구강 위생에 대한 인식 증가, 의료 인프라 확대, 유리한 상환 정책 시행 등입니다.
효과적인 치료를 위해 첨단 임플란트 솔루션을 필요로 하는 정형외과 및 치과 질환의 유병률 증가가 세계 골유착 임플란트 시장을 주도하고 있습니다. 이와 더불어 교통사고로 인한 사망자 수 증가, 골관절염 및 류마티스 관절염 환자 증가로 인해 인공관절 치환술 및 인공 무릎관절 치환술에 대한 필요성이 증가하고 있습니다. 이에 따라 최소침습수술(MIS)에 대한 소비자의 선호도가 높아져 시장 성장을 견인하고 있습니다. 이와 더불어, 내구성, 생체 적합성, 기능성을 향상시키는 치료와 관련된 성장과 기술 혁신이 시장 개척에 박차를 가하고 있습니다. 예를 들어, 2024년 3월 28일 Osstem Implant는 치유를 개선하고 초기 골 형성을 강화하는 차세대 슈퍼 골유착(SOI) 표면 처리를 자랑하는 TSIII SOI 임플란트(TSIII SOI Implant)를 출시했습니다. 이 새로운 표면 처리는 UV와 HEPES 완충제를 사용하여 초친수성 코팅을 형성하여 생체적합성을 높이고 골유착 기간을 최대 6개월에서 약 2개월로 단축시킵니다. 이와는 별도로 선진국 및 신흥국 시장에서 골유착 임플란트의 보급을 촉진하기 위해 의료비 지출 증가, 정부 지원 정책, 최소침습 수술 기술의 채택 확대가 촉진하고 있습니다.
미국 시장은 재활 및 회복을 위해 첨단 임플란트 솔루션이 필요한 스포츠 관련 부상 및 외상 유병률 증가로 인해 큰 영향을 받고 있습니다. 당뇨병 및 혈관 질환과 같은 만성 질환의 유병률이 증가하고 사지 절단으로 이어지는 경우가 많기 때문에 골 통합형 의족 시스템에 대한 수요가 증가하고 있습니다. 또한, 잘 구축된 의료 인프라와 강력한 상환 정책은 의료 제공업체와 환자들 사이에서 이러한 첨단 임플란트의 채택을 촉진하고 있습니다. 또한, 특히 기능적 및 미적 개선을 원하는 사람들 사이에서 미용 및 재건 수술에 대한 수요가 증가하고 있는 것도 시장 성장에 기여하고 있습니다. 이와 더불어, 미국에 기반을 둔 의료기기 제조업체들의 광범위한 연구개발 활동과 미국 내 골유착형 임플란트 기술의 혁신도 시장 성장에 기여하고 있습니다. 예를 들어, 2024년 9월 9일, 신텍스 테크놀로지는 지르코니아 강화 알루미나(ZTA) 표면에 생체 활성 실리콘 질화물을 접착하는 방법에 대한 USPTO 특허를 허가받았습니다. 신텍스는 지속적으로 지적재산권 포트폴리오를 확장하고 있으며, 현재 16건의 미국 특허를 보유하고 있습니다.
뼈 관련 질환 증가
골관절염, 골다공증, 선천성 기형과 같은 뼈 질환 증가가 골유착 임플란트 사용의 한 요인으로 작용하고 있습니다. 전 세계적으로 노인 인구가 지속적으로 증가함에 따라 골유착 공정을 이용한 수술, 특히 치과 및 정형외과용 보철물에 대한 수요가 증가하고 있습니다. 인구통계학적으로 고령인구가 많은 신흥국 시장에 대한 수요가 증가하고 있습니다. 세계보건기구(WHO)의 추산에 따르면 2019년 전 세계적으로 약 5억 2,800만 명이 골관절염을 앓고 있으며, 이는 1990년 대비 113% 증가한 수치입니다. 또한, 골관절염 환자의 73%는 55세 이상입니다. 또한, 이들 중 60%가 여성입니다. 결과적으로 노인 인구의 골관절염 유병률 증가는 이들 환자 대부분이 인공관절 치환술과 같은 시술을 필요로 하기 때문에 골유착 임플란트의 필요성을 증가시키고 있습니다. 이처럼 골유착 임플란트 시장은 인구 고령화와 뼈 질환 증가로 인해 크게 성장하고 있습니다.
기술 발전
임플란트 표면의 재료, 코팅 및 기술의 혁신은 골유착 임플란트의 효과와 효율성에 혁명을 가져왔습니다. 시장 개척은 티타늄 및 그 합금을 포함한 생체 적합성 재료의 개발로 더욱 촉진되어 이러한 임플란트의 높은 성공률을 보장하고 환자는 내구성과 편안함을 경험하고 있습니다. 또한, 새로운 3D 프린팅 기술은 맞춤형 임플란트를 제작할 수 있는 가능성을 제공하여 치료 결과와 환자 만족도를 향상시키고 있습니다. 이러한 기술 혁신은 의료 서비스 제공업체의 골유착형 임플란트 보급을 촉진하고 비용뿐만 아니라 접근성을 용이하게 하며, 키스톤 덴탈 홀딩스는 2023년 11월 제네시스 액티브(GENESIS ACTIVE) 임플란트 시스템을 발표했습니다. 이러한 기술 혁신의 한 예로 키스톤 덴탈 홀딩스가 2023년 11월에 발표한 새로운 제네시스 액티브 임플란트 시스템(GENESIS ACTIVE Implant System)의 진보를 들 수 있습니다. 이 치과 임플란트 수술 솔루션은 이 분야의 임플란트 식립과 수복을 발전시킬 것입니다. 지속적인 기술 발전은 임플란트 시술의 전반적인 프로세스를 보다 효율적으로 만드는 동시에 환자의 예후를 개선하고 있으며, 골유착 임플란트 시장의 성장을 주도하고 있습니다.
심미적이고 기능적인 임플란트에 대한 수요 증가
특히 치과 분야에서 기능적 이점과 심미적 향상을 통합한 임플란트에 대한 수요 증가는 골유착 시장의 중요한 성장 동력으로 작용하고 있습니다. 골유착 임플란트는 기능적 및 심미적 이점을 모두 제공하는 영구적이고 자연스러운 결손된 치아를 대체할 수 있습니다. 따라서 삶의 질을 향상시키고자 하는 환자들 사이에서 높은 수요가 있으며, 주로 지역 전반에 걸친 의료 접근성 및 인식 개선에 힘입어 2024년 세계보건기구(WHO)의 구강 위생에 관한 보고서는 전 세계적으로 구강 위생 문제가 여전히 심각하다는 것을 반영하고 있습니다. 반영하고 있습니다. 영구치 우식증으로 고통받는 사람들과 약 5억 1,400만 명의 어린이들이 약 20억 명에 달할 것으로 추산되며, 골유착 임플란트와 같은 더 나은 치과 솔루션에 대한 엄청난 수요를 계속 제시합니다. 이러한 첨단 치과 치료에 대한 수요 증가는 전 세계 골유착 임플란트 시장 확대의 큰 원동력이 되고 있습니다.
The global osseointegration implants market size was valued at USD 7,114.18 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 11,342.32 Million by 2033, exhibiting a CAGR of 5.05% from 2025-2033. North America currently dominates the market, holding a market share of over 55.8% in 2024. The market is primarily driven by the increasing aging populations, rising demand for dental and orthopedic procedures, advancements in implant technologies, growing awareness about oral health, expanding healthcare infrastructure, and the implementation of favorable reimbursement policies.
The increasing prevalence of orthopedic and dental disorders, which require advanced implant solutions for effective treatment, is driving the global osseointegration implants market. In addition to this, the increasing number of fatal road traffic accidents and the growing number of individuals suffering from osteoarthritis and rheumatoid arthritis increases the need for joint and knee replacement surgeries. This leads to increasing consumer preferences for minimally invasive surgeries (MIS), which is propelling the growth of the market. Besides this, growth and innovations related to treatments improving durability, biocompatibility, and functionality, are fueling the market development. For instance, on March 28, 2024, Osstem Implant launched its TSIII SOI implant which boasts of the next-generation Super Osseointegration (SOI) surface treatment that improves healing and strengthens initial bone formation. This new surface treatment uses UV and HEPES buffering agents to create a super-hydrophilic coating that enhances biocompatibility and reduces the osseointegration period from up to six months to about two months. Apart from this, it is supported by the increasing healthcare expenditure, supportive government policies, and the growth in the adoption of minimally invasive surgical techniques for promoting the mass penetration of osseointegration implants in the developed and emerging markets.
The market in the United States is majorly influenced by the growing prevalence of sports-related injuries and trauma cases, which demand advanced implant solutions for rehabilitation and recovery. The rising incidence of chronic conditions like diabetes and vascular diseases, often leading to limb amputations, drives the demand for osseointegrated prosthetic systems. Moreover, a well-established healthcare infrastructure and strong reimbursement policies promote the adoption of these advanced implants among healthcare providers and patients. Additionally, the rising demand for cosmetic and reconstructive surgeries, particularly among individuals seeking functional and aesthetic enhancements, contributes to market growth. Besides this, the extensive research and development (R&D) activities undertaken by U.S.-based medical device manufacturers and the innovation of osseointegration implant technologies in the country. For example, on September 9, 2024, SINTX Technologies received a notice of allowance for a USPTO patent covering methods to bond bioactive silicon nitride to zirconia-toughened alumina (ZTA) surfaces. The company continues to grow its intellectual property portfolio, now holding 16 U.S. patents.
Growing Prevalence of Bone-related Disorders
Increasing incidences of bone conditions such as osteoarthritis, osteoporosis, and congenital anomalies are contributing factors to the use of osseointegration implants. An ever-growing elderly global population increases the desire for surgical operations using osseointegration processes, especially on dental and orthopedic prosthetics. There is an intensified demand for developed markets that account for older populations in their demographic groups. The World Health Organization estimates that around 528 million people across the globe were living with osteoarthritis in 2019, a 113% increase from 1990. In addition, 73% of individuals with osteoarthritis are aged 55 years and above. Moreover, 60% of these individuals are women. As a result, this increased prevalence of osteoarthritis among the elderly population is driving up the need for osseointegration implants since most of these patients require procedures like joint replacements. Thus, the osseointegration implants market is growing considerably due to an ageing population and a growing number of bone disorders.
Technological Advancements
Innovations in the materials, coatings, and techniques of implant surface are revolutionizing the efficacy and efficiency of osseointegration implants. Growth in the market is further fueled by the development of biocompatible materials, including titanium and its alloys, that ensure higher success rates for such implants, with patients experiencing durability and comfort. Also, the new 3D printing technologies are offering the possibility to create customized implants, thus bettering outcomes and patient satisfaction. These innovations increase osseointegration implant uptake by healthcare service providers and ease accessibility as well as their cost. Keystone Dental Holdings rolled out the GENESIS ACTIVE Implant System during November 2023. An example of such innovation is seen with the advancement of the new GENESIS ACTIVE Implant System, with Keystone Dental Holdings announcing it in November 2023. This dental implant surgical solution advances placement and restoration for the sector. Continued technological advancements are improving patient outcomes while making the overall process of implant procedures more efficient, and it is driving growth in the osseointegration implants market.
Rising Demand for Aesthetic and Functional Implants
The growing demand for implants that integrate functional advantages with aesthetic enhancement, especially in dental application, acts as a significant growth driver for the osseointegration market. Osseo integration implants provide a permanent and natural replacement of missing teeth that provides both functional and aesthetic advantages. This makes them highly in need among patients looking forward to improving the quality of their life, mainly driven by improving access and awareness in healthcare across the regions. In 2024, the World Health Organization report on oral health continues to reflect that oral health issues persist in the global scene. Estimated to have reached several about 2 billion, people suffering from caries in permanent teeth, and approximately 514 million children with caries in primary teeth, continue to present such immense demands for better dental solutions such as osseointegration implants. This growing demand for advanced dental care is a significant driving force behind the expansion of the osseointegration implants market across the world.
Bone-anchored prostheses lead the market in 2024. Bone-anchored prostheses are considered a revolutionary solution for those individuals requiring limb replacement or rehabilitation. The advanced nature of these prosthetic products makes use of osseointegration technology, which involves the direct integration of an implant with bone tissue, thereby offering stability, functionality, and comfort more than socket-based prosthetics. Their growing adoption is due to the increasing prevalence of amputations due to trauma, diabetes, and vascular diseases, coupled with rising awareness about advanced prosthetic options. Users in developed as well as developing markets witness high demand as bone-anchored prostheses can enhance their movement, diminish their pain and even improve the quality of their lives. Besides, the continuous development of implant materials and surgical procedures further enhances their market potential, which makes bone-anchored prostheses a significant product in the osseointegration implant market.
Metallic leads the market with around 63.5% of market share in 2024. Metallic materials are the mainstay of growth in the global osseointegration implants market, as they have excellent biocompatibility, durability, and mechanical strength. The most widely used metals, such as titanium and its alloys, are preferred for their osseointegration capability, especially for establishing a stable bonding with the bone tissue. These materials are resistant to corrosion and wear, which ensures the long-term functionality and reliability of implants used in dental, orthopedic, and maxillofacial applications. The growing need for durable, high-performance implants, especially for the aging population and for patients with trauma or degenerative conditions, gives vital significance to metallic materials in this market. Moreover, novel techniques in metal fabrication, for example, 3D printing and surface coating technologies, positively impact implant customization while further enhancing patient benefits.
Hospitals lead the market with around 65.9% of market share in 2024 due to the extensive provision of different types of medical services and surgical procedures that are provided for patients seeking proper care. Hospitals have an enormous client base with various types of patients in need of osseointegration implants. Patients may suffer from orthopedic, dental, or maxillofacial disorders and could be survivors of trauma and cancer requiring reconstruction solutions. A growth in surgeries combined with hospital admission due to the prevalence of conditions requiring implantation augments the demand for osseointegration implants. In addition to this, government and private investments in hospital facilities, especially in emerging economies, increase access to quality care, which in turn propels the growth of the market. Hospitals' ability to provide complete post-operative care and rehabilitation ensures optimal patient outcomes, which further strengthens their role in the expansion of the osseointegration implant market.
In 2024, North America accounted for the largest market share of over 55.8% due to advanced healthcare infrastructure, high adoption rates of innovative medical technologies, and a well-established regulatory framework. The increasing elderly population in the region and rising cases of trauma, osteoporosis, and dental conditions significantly fuel the demand for osseointegration implants. Countries like the United States and Canada have huge healthcare spending, strong reimbursement policies, and a strong presence of leading industry players, which fosters rapid adoption of advanced implants. Additionally, research and development (R&D) activities are further supported by funding from the government as well as the private sector to enhance product innovation and patient outcomes. With an increase in awareness regarding the advantages of osseointegration and a large percentage of the population suffering from chronic conditions requiring implants, North America is an essential contributor to the growth of the market. Its proactive attitude toward the adoption of cutting-edge medical solutions ensures sustained importance in the global market.
United States Osseointegration Implants Market Analysis
The United States is a significant region in the osseointegration implants market with the market share of 89.30%, due to the rise in the number of people with arthritis and mobility problems. According to the CDC, a report in 2024 stated that about 58.5 million adults aged 18 years and older are living with arthritis in the United States, with 25.7 million experiencing activity limitations due to arthritis. The projections indicate that, by 2040, this number will surge to 78 million adults, and this population is surely aged, attributed also to lifestyle, in musculoskeletal conditions. Arthritis is a primary cause of disability and surely does require surgical intervention like joint replacements, where osseointegration implants improve mobility and quality of life. Growing demand for advanced implants made from biocompatible materials, along with the increasing awareness of healthcare, is driving the growth of the market. In addition, efforts to increase access to orthopedic care are expected to boost the demand for osseointegration solutions in the United States.
Europe Osseointegration Implants Market Analysis
The Europe osseointegration market is expected to rise significantly due to the aging population in the region and the rise in osteoporosis. On January 1, 2023, the European Union population was 448.8 million, with one-fifth, or 21.3%, aged 65 years or above, according to the European Commission. This indicates the growing needs for medical interventions, such as osseointegration implants, to treat the bone-related condition associated with advancing age. Additionally, osteoporosis remains a serious health issue in Europe, where over 23 million people are at high risk of osteoporotic fractures, as NIH data in 2021 indicates. The majority of such fractures require surgery and implantation, which means the demand for more advanced osseointegration technologies is increased. Moreover, solid healthcare infrastructure combined with innovations happening in implantable materials and surgical techniques increase the success ratio of treatments for osseointegration, giving Europe a large market for its solutions.
Asia Pacific Osseointegration Implants Market Analysis
The Asia Pacific osseointegration implants market has high growth potential, as the region has a rapidly aging population and is witnessing rising osteomyelitis, among other bone-related disorders. According to NIH, the population aged 65 or older in China will grow more than double from 172 million or 12.0% of total population in 2020 to 366 million or 26.0% by 2050. This demographic change gives rise to increasing demand for state-of-the-art healthcare services. This encompasses conditions such as osteoporosis, arthritis, and joint degeneration, in addition to osseointegration implants. Also, the healthcare infrastructure is becoming more advanced within the region. There are enhanced investments in the medical technology space, thus paving the way for growth. It includes Japan-one of the most geriatric countries and India- one of the increasing healthcare conscious ones. Advances in implant materials, including personalized 3D printing of implants, improve success rates. Therefore, osseointegration implants are witnessing significant growth as the leading market area in the Asia Pacific region.
Latin America Osseointegration Implants Market Analysis
The Latin American osseointegration implants market is growing due to the increasing orthopedic disorder prevalence, primarily in Brazil. In this region, the growing demand for hip replacement surgeries supports the market expansion. According to estimates from the Brazilian Hip Society, there are about 70,000 hip arthroplasties performed annually. Only 17,000 of them are publicly funded, according to an NCBI report in 2020. Thus, this situation presents a sizeable opportunity for private healthcare service providers to help bridge the ever-growing demand gap for hip replacement and osseointegration implants. The aging population in Latin America and the rising awareness of advanced medical technologies are also contributing to the need for high-quality orthopedic implants. As more patients seek personalized and long-lasting solutions for conditions like osteoarthritis and osteoporosis, the market for osseointegration implants in Latin America is expected to continue its growth. The region is heading for tremendous gains in implant technology and patient care, thus offering some great opportunities that are expected in the coming years.
Middle East and Africa Osseointegration Implants Market Analysis
The Middle East and Africa (MEA) osseointegration implants market is witnessing significant growth with the increasing incidence of bone-related disorders like osteoarthritis (OA) and rising investments in healthcare. According to the NIH, the standardized prevalence of OA in the MENA region was 5,342.8 cases per 100,000 in 2019. This number rose by 9.3% from 1990. The growing case of OA, which is greatly promoted through the aging population, fuels the need for joint replacement surgeries, a scenario where osseointegration implants are fundamental. Additional strength to the increased demand for superior medical technologies that include osseointegration implants is provided with the increasing regional healthcare spending-estimated to stand at USD 135.5 Billion by the year 2027 in GCC, as per reports. Moreover, the rising preference and adoption of innovative and highly biocompatible materials in solutions from implant technology, which is currently enhancing the whole market growth through the MEA region.
The osseointegration implants market at the global level is highly competitive, with key manufacturers focusing on innovation, technology, and differentiation in products. The key companies majorly emphasize the research and development (R&D) activities of implant design, biocompatibility, and long-term durability. Companies have been investing significantly in minimally invasive solutions and personalized implants in order to bring better patient results. Market players are trying to increase their geographies through partnerships, collaboration, and distribution agreements. Rising consumption of advanced materials such as titanium and ceramic help in further innovation. Manufacturers target emerging markets by providing cost-effective solutions, which impact the market dynamics.